Clinical Trial Update: Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

View source ↗

Summary

It reports a clinical trial developing a multi-omics model to predict immunotherapy response in triple-negative breast cancer subtypes; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences | Conditions: Breast Neoplasms | Status: ACTIVE_NOT_RECRUITING